Schedule 13G ownership disclosure

Paratek Pharmaceuticals Inc

Security class unavailable · CUSIP: 699374302

Event date: 2022-05-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,210,552
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-22-000349
Form type
SC 13G
Filer
LYTTON LAURENCE W
CIK
CIK 1105806
Filed
May 18, 2022
Reporting period
May 09, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub